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Visceral leishmaniasis (VL, also known as kala-azar) is the second largest parasitic killer in the world 
after malaria, responsible for an estimated 200 000 – 
400 000 cases each year worldwide;1 90% of the global 
burden occurs in just six countries: India, Bangladesh, 
Sudan, South Sudan, Ethiopia and Brazil. The infecting 
parasite is of the Leishmania donovani complex, and in-
fection occurs in humans as a result of being bitten by 
an infected female Phlebotomine sandfly. In VL, the dis-
ease is visceral, with the parasites migrating to internal 
organs; signs and symptoms include fever, weight loss, 
cachexia and anaemia. 
The gold standard for the diagnosis of VL is the 
demonstration of amastigotes in tissue aspirates from 
the spleen, followed by bone marrow or lymph nodes; 
however, due to technical constraints, serology is now 
more frequently used.2 In areas where leishmaniasis is 
endemic, the rK-39 dipstick test (Kalazar Detect® Rapid 
Test; InBios International, Seattle, WA, USA) is there-
fore used with finger-prick blood samples; in South-
East Asia, this has excellent sensitivity (99–100%) and 
specificity (96–98%).3,4 The treatment of choice was 
traditionally with pentavalent antimonials; however, 
this therapy is toxic, associated with iatrogenic mor-
tality, and resistance has developed, particularly in In-
dia, resulting in treatment failure. Current treatment 
regimens now include various preparations of ampho-
tericin B and miltefosine.
Post-kala azar dermal leishmaniasis (PKDL) is a se-
quela of VL that manifests as a skin rash in a patient 
after successful treatment for VL who is otherwise 
well. The rash is characteristic and usually macular in 
nature, and the diagnosis is mainly clinical. Available 
confirmatory tests are not very sensitive for macular 
lesions. PKDL is a potential reservoir for ongoing 
transmission of infection,5 particularly in the Indian 
subcontinent.
In Bangladesh, humans are the only known reser-
voir of the infection and therefore, with early diagno-
sis and treatment of VL and PKDL, it should be possi-
ble to reduce the incidence rates of these diseases 
drastically. The Government of Bangladesh aims to re-
duce the annual incidence of VL at the subdistrict 
level to below 1 per 10 000 by 2015.6 The detection 
and diagnosis of VL and PKDL in Bangladesh is mainly 
through a passive case detection strategy. In the case 
of PKDL, few patients come forward for diagnosis and 
treatment, as in most cases it presents only as hypo-
pigmented macules that do not cause physical impair-
ment. As a result, many PKDL cases in the community 
are undiagnosed and untreated and remain a source of 
Leishmania transmission.
Médecins Sans Frontières (MSF) started working in 
the Fulbaria subdistrict of Mymensingh District in 
Bangladesh in April 2010, with the specific aim of 
controlling VL and PKDL through an active case de-
tection (ACD) strategy combined with provision of 
free treatment for both VL and PKDL with short-
course liposomal amphotericin B. 
The aim of the present study was to describe the 
results of the ACD strategy for VL and PKDL at the 
subdistrict level in Bangladesh, and to compare the re-
sults with those obtained in a neighbouring subdis-
trict where a passive case detection (PCD) strategy has 
remained standard practice. Specific objectives were to 
determine 1) the numbers of patients, stratified by age 
and sex, diagnosed with VL and PKDL in two subdis-
tricts, one with an ACD and the other with a PCD 
strategy, and 2) in the ACD subdistrict, the length of 
time from onset of symptoms to diagnosis. 
METHODS
Study design
This is a cross-sectional descriptive study based on re-
cord review.
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Setting: Two subdistricts in Bangladesh, Fulbaria and Tri-
shal, which are hyperendemic for leishmaniasis. 
Objective: To determine 1) the numbers of patients di-
agnosed with visceral leishmaniasis (VL) and post-kala 
azar dermal leishmaniasis (PKDL) using an active case de-
tection (ACD) strategy in Fulbaria and a passive case de-
tection (PCD) strategy in Trishal, and 2) the time taken 
from symptoms to diagnosis in the ACD subdistrict.
Design: A cross-sectional descriptive study of patients diag-
nosed from May 2010 to December 2011. The ACD strat-
egy involved community education and outreach workers 
targeting households of index patients using symp-
tom-based screening and rK-39 tests for suspected cases.
Results: In the ACD subdistrict (Fulbaria) and PCD sub-
district (Trishal), respectively 1088 and 756 residents 
were diagnosed with VL and 1145 and 37 with PKDL. In 
the ACD subdistrict, the median time to diagnosis for pa-
tients directly referred by outreach workers or self-re-
ferred was similar, at 60 days for VL and respectively 345 
and 360 days for PKDL.
Conclusion: An ACD strategy at the subdistrict level re-
sulted in an increased yield of VL and a much higher yield 
of PKDL. As PKDL acts as a reservoir for infection, a strat-
egy of ACD and treatment can contribute to the regional 
elimination of leishmaniasis in the Indian sub-continent.
Setting 
General
Bangladesh is a country with a population of 170 mil-
lion, 40% of whom live below the poverty line.7 VL is 
endemic in 41 districts in the country, with an annual 
VL case burden of approximately 6000 over the past 
10 years.8,9 However, the epicentre of the disease is in 
Mymensingh District, which accounts for approxi-
mately 60% of all cases in the country.
Study sites
Mymensingh District, the focus of the study, is situ-
ated approximately 150 km north of Dhaka, the cap-
ital city. In 2007, 80% of VL cases from Mymensingh 
District occurred in just two subdistricts, Fulbaria 
and Trishal. These two subdistricts are adjacent to 
each other and comparable socio-demographically 
and geographically. The population of each of these 
subdistricts at the time of the study was approxi-
mately 400 000,7 with most people living in rural 
settings. Table 1 shows the socio-demographic char-
acteristics of the population, the health care infra-
structure of the two subdistricts and the annual case 
burden of VL in the two subdistricts between 2005 
and 2008. 
The PCD subdistrict (Trishal)
In Trishal subdistrict, patients were diagnosed and 
treated using a PCD strategy. Patients self-referred to 
health centres, where diagnosis and treatment were 
carried out using the same diagnostic tests as the in-
tervention district but with different treatment regi-
mens based on pentavalent antimony and miltefos-
ine. Leishmaniasis-specific community education was 
non-existent. In Trishal, all data were kept in a general 
VL and PKDL register in the Upazilla health complex 
(UHC). 
The ACD subdistrict (Fulbaria)
In May 2010, the MSF started a leishmaniasis project 
in Fulbaria subdistrict with an ACD strategy superim-
posed on the PCD system. The MSF Operational Cen-
tre Amsterdam recruited and trained outreach workers 
(ORWs) on how to identify a suspected case of VL and 
PKDL and perform rK-39 tests in the field. The ORWs 
were based at village level and visited households on a 
regular basis to screen for VL and PKDL. ORWs with at 
least 12 years of formal school education received 
both theoretical and hands-on training from the MSF. 
The number of ORWs over the course of the project 
varied from 25 to 35. 
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TABLE 1 Socio-demographic characteristics, access to health care and annual case burden 
of VL in Fulbaria and Trishal subdistricts, Bangladesh
Fulbaria Trishal
Area, km2 399 338
Households, n 101 189 93 886
Total population, n 448 467 419 203
Average household size 4.4 4.4
Male:female ratio 1:1 1:1
Population distribution by age, years
 0–4 11.7% 12.5%
 5–14 26.5% 27.4%
 15–49 46.6% 45.7%
 49 15.2% 14.4%
Heath infrastructure
Upazilla health complex* 1 1
Union subcentre† 4 4
Union health and family welfare centre† 9 10
Community clinics 40 41
Referral hospital Mymensingh Medical 
College Hospital with 
good communication
Mymensingh Medical 
College Hospital with 
good communication
Neonatal mortality rate, /1000 live births 22.7 20.7
Maternal mortality rate, /100 000 live births 145.4 148.6
Annual number of VL cases detected
 2005 1239 1492
 2006 1699 1230
 2007 1201 1128
 2008 1395 1492
* The only public hospital at the subdistrict level, which offers in-patient service and serves as the referral point for 
the Union subcentre, Union health and family welfare centre and community clinics. These form the primary health 
care service network in Bangladesh.
† A ‘Union’ is the administrative subdivision of a subdistrict (or upazilla) that serves the community at the Union 
level. It offers free but limited out-patient health care services, and uses the upazilla health complex as the referral 
point. 
VL = visceral leishmaniasis.
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Screening was carried out in the households of index patients 
treated at the MSF clinic. Using this approach, the house of an in-
dex patient was visited, as were all other households within a 
200 m radius, called a cluster. The approach is based on the flight 
characteristics of the sandfly.10 In this targeted approach, MSF 
ORWs visited each cluster every 2 months up to three or four 
times until it was decided that no further cases could be found. 
When multiple patients came from the same household or from a 
close neighbourhood, instead of creating multiple new clusters, 
only one cluster was created around that household or neigh-
bourhood, which was subsequently visited three or four times. 
During the study period, 1858 new clusters (37 160 households 
with a population of 163 504) were covered. Of all the clusters, 
68% were visited 3 times, and 75% of the new clusters were 
formed within 14 days after the index case was diagnosed as hav-
ing either VL or PKDL. 
Screening was carried out using a symptom- and sign-based 
strategy. After identification of a clinically suspect person, a sero-
logical test was performed in the home using an rK39 dipstick. 
The positivity rate of the rK-39 tests performed by the ORWs in 
the community was approximately 40% for VL and 75% for sus-
pected PKDL cases. If positive, the patient was referred to the 
MSF-OCA clinic for clinical assessment and diagnosis by a physi-
cian and treatment. PKDL was diagnosed on clinical grounds and 
by a positive rK-39 test. If VL and PKDL were confirmed either 
clinically or by identifying amastigotes in tissue aspirates, treat-
ment was given with liposomal amphotericin B. 
In addition to screening, health education on VL and PKDL 
was provided to the community. 
Since the project started in April 2010, the MSF has treated ap-
proximately 1400 VL and 1300 PKDL patients. All clinical, diag-
nostic and treatment data are kept in medical files, and a special 
electronic database is maintained. In addition, the outreach data 
were kept in a register that also served as a source of information.
Study population
All patients, irrespective of age and sex, who were diagnosed in 
the period between May 2010 and December 2011 with VL and 
PKDL and were residents of Fulbaria and Trishal were included in 
the study. 
VL and PKDL were defined as follows: a person from an en-
demic area with a history of fever for 2 weeks, weight loss and 
splenomegaly and either a positive serological test rK-39 or with 
parasites found in aspirated specimens of spleen, was considered 
to have VL.8 A person with a previous history of VL with typical 
PKDL lesions (hypopigmented dermal lesions which can be macu-
lar, papular, nodular or of mixed type), with no loss of skin sensa-
tion and with a positive rK-39 test was diagnosed as PKDL.8 
Data variables, data collection instrument and sources of 
data
The variables collected for confirmed VL and PKDL cases included 
location, age, weight, sex, address, date of onset of symptoms, 
date of diagnosis, diagnosis, date of start of treatment, the num-
ber of households visited by ORWs for each case and the number 
of patients diagnosed and admitted for treatment. For PKDL, the 
time between onset of symptoms and diagnosis was collected in 
months and converted to days for presentation. Data were col-
lected into a structured proforma. The sources of data were the 
patient database and outreach registration books for Fulbaria 
(ACD), and the VL/PKDL register kept in the Trishal Upazilla 
Health Complex and the annual overview record kept at the Min-
istry of Health in Dhaka for Trishal (PCD).
Analysis and statistics 
Data from the structured proforma were double entered into an 
EpiData version 3.1 (EpiData Association, Odense, Denmark) and 
analysed using SPSS version 11.5 (Statistical Product and Service 
Solutions, Chicago, IL, USA) and Microsoft Excel 2007 (Micro-
soft, Redmond, WA, USA). Simple frequency analysis was con-
ducted and tables were constructed in a categorical way and pre-
sented in charts and diagrams to describe the study population. 
Some of the continuous variables were converted into categorical 
variables for further statistical tests using the χ2 test with 95% 
confidence intervals as appropriate. Levels of significance were 
set at 5% (P  0.05). 
Ethics approval
This study met the MSF (Geneva, Switzerland) Ethics Review 
Board-approved criteria for analysis of routinely collected pro-
gram data. It was also approved by the Ethics Advisory Group of 
the International Union Against Tuberculosis and Lung Disease, 
Paris, France. Permission was obtained from the Director of Com-
municable Disease Control, Ministry of Health, Dhaka, 
Bangladesh.
RESULTS
Respectively 2181 and 1316 patients were diagnosed with VL and 
PKDL in the two subdistricts. Figure 1 shows the number of pa-
tients diagnosed with VL who were residents, and of these, the 
number identified in the ACD and PCD subdistricts. Of all the 
residential patients, 59% were detected in the ACD subdistrict. 
However, there was contamination of patients between the two 
subdistricts, with 170 (16%) VL patients living on the border of 
the PCD subdistrict being diagnosed in the ACD subdistrict and 
three (1%) patients living on the border of the ACD subdistrict 
being diagnosed in the PCD subdistrict. Figure 2A shows the 
number of patients diagnosed with VL each month during the 
pre-study period in 2008 in Fulbaria (n = 1395) and Trishal (n = 
1492), when PCD was the normal form of screening in both the 
subdistricts. More VL cases were detected overall in Trishal, but 
the seasonal variation was similar in the two subdistricts. Figure 
2B shows the number of patients diagnosed with VL during the 
study period in Fulbaria and in Trishal with the ACD and PCD 
strategies, respectively. Although seasonal variation was again 
similar, this time more VL cases were diagnosed in the ACD 
subdistrict. 
Figure 3 shows the number of patients diagnosed with PKDL 
who were residential, and of these, the number identified in the 
ACD and PCD subdistricts. Of all the residential patients, 97% 
were detected in the ACD subdistrict. There was also contamina-
tion of patients between the two subdistricts, with 70 (6%) PKDL 
patients from the PCD subdistrict who lived on the border being 
diagnosed in the ACD subdistrict and none vice versa. In the ACD 
subdistrict, 195 (18%) patients with VL and 667 (58%) with PKDL 
were directly referred by ORWs to the MSF treatment centre, 
while the remaining patients were self-referred. 
The mean age of the patients with VL and PKDL was respec-
tively 18 (standard deviation [SD] ± 15) and 23 years (SD ± 15) in 
the ACD subdistrict, and 21 (SD ± 18) and 16 years (SD ± 10) in 
the PCD subdistrict. Demographic characteristics in terms of sex 
and age groups between the two subdistricts in patients with VL 
and PKDL are shown in Table 2. With VL, the proportions of 
males and females were similar, but there were some significant 
(although not important) differences in proportions of patients in 
the different age groups. With PKDL, no differences were found. 
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The median time from onset of symptoms and/or signs to di-
agnosis in patients referred by ORWs and those self-referred in 
the ACD subdistrict is shown in Table 3. In patients with VL, the 
median time to diagnosis in the two groups was similar, at 60 
days. In patients with PKDL, the median time to diagnosis was 
also similar, at 360 and 345 days for the two groups. 
DISCUSSION
This is the first report to compare the use of ACD and PCD strate-
gies in the detection of VL and PKDL in a routine setting of two 
subdistricts in Bangladesh. The number of cases diagnosed with 
VL was generally similar in the two subdistricts when a PCD strat-
egy was used in both. However, the number of VL cases increased 
when an ACD strategy was introduced. A striking finding was the 
considerably higher number of cases diagnosed with PKDL when 
an ACD strategy was introduced. 
These findings make intuitive sense. VL is a systemic disease 
characterised by fever, weight loss and wasting, and these symp-
toms are likely to drive patients to seek health care whether or 
not they have been screened by ORWs, who in any case conduct 
targeted outreach activities once every 2 months. It was interest-
ing to note that the median time from onset of symptoms to di-
agnosis in patients in the ACD subdistrict was 2 months whether 
they were referred directly by an ORW or self-referred, which cor-
roborates this interpretation. 
In contrast, PKDL is a skin disease, and the patient feels other-
wise well; an ACD strategy may thus be more likely to result in 
patients being referred to health facilities for diagnosis and care. 
FIGURE 1 Patients with visceral leishmaniasis detected using active 
and passive case-finding strategies in two hyperendemic subdistricts 
of Bangladesh, May 2010 – December 2011. 
FIGURE 2 Number of patients detected each month with VL in Fulbaria and Trishal subdistricts before 
and during the study periods. A) Monthly VL cases detected in 2008 (passive case detection by MoH in 
both subdistricts); B) monthly VL cases detected in 2010 and 2011 in Fulbaria (active case detection by 
Médecin Sans Frontières) and in Trishal (passive case detection by MoH) during the study period. VL = vis-
ceral leishmaniasis; MoH = Ministry of Health.
FIGURE 3 The number of patients with post-kala azar dermal leish-
maniasis detected using active and passive case-finding strategies in 
the two hyperendemic subdistricts of Bangladesh, May 2010 – De-
cember 2011.
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In the ACD subdistrict, nearly 60% of the patients with PKDL 
were directly referred by ORWs to the treatment centre, but the 
remainder were self-referred, which is probably a positive effect of 
the health education conducted in the community. The long de-
lay of almost 1 year between onset of skin lesions and diagnosis 
reflects the benign nature of this disease. 
The strengths of this study were the large size and comparabil-
ity of the subdistricts in terms of socio-demographic characteris-
tics and health infrastructure, the large number of patients diag-
nosed with VL and PKDL and the excellent database and 
monitoring system set up in the ACD subdistrict. The limitations 
relate to the operational nature of the study, in which patients 
from Trishal (the PCD subdistrict) living on the border areas came 
over to Fulbaria (ACD subdistrict), providing some degree of 
cross-contamination between the two strategies. However, this 
type of practice, with transferrals from one administrative area to 
another to seek diagnosis and care, is common in low- and mid-
dle-income countries, and is an operational reality in the field. 
The other limitations relate to the different treatment regimens 
used in the two subdistricts, and the record keeping of the PCD 
TABLE 2 Patients detected with VL and PKDL, stratified by sex and age according to active and passive 
case-finding approaches in Fulbari and Trishal subdistricts, Bangladesh, May 2010 to December 2011
Active case finding approach (Fulbaria) Passive case finding approach (Trishal) P
n % (95%CI) n % (95%CI)
VL
 Total, n 1087 756 
 Sex
  Male 624 57 (54–60) 419 55 (51–58) 0.4
  Female 463 43 (38–46) 337 45 (41–48) 0.4
 Age, years
  Mean 18 (3–33) 21 (3–39) 0.001
  Median 12 (1–80) 15 (1–85)
  0–5 182 17 (15–19) 113 15 (12–17) 0.3
  6–14 440 40 (37–43) 240 32 (29–35) 0.001
  15–30 270 25 (22–28) 221 29 (26–32) 0.04
  31–45 115 11 (9–13) 91 12 (10–14) 0.3
  45 80 7 (5–8) 91 12 (10–14) 0.001
PKDL
 Total, n 1145 37 
 Sex
  Male 644 56 (53–59) 19 51 (35–67) 0.55
  Female 501 44 (41–47) 18 49 (33–65) 0.5
 Age in years
  Mean 23 (8–38) 16 (6–26) 0.01
  Median 18 (2–90) 15 (2–40)
  0–5 43 4 (3–5) 4 11 (1–21) 0.1
  6–14 450 39 (36–42) 16 43 (27–59) 0.6
  15–30 358 31 (28–34) 14 38 (22–53) 0.4
  31–45 192 17 (15–19) 3 8 (0–17) 0.2
  45 102 9 (7–11) 0 0 NA
VL = visceral leishmaniasis; PKDL = post–kala azar dermal leishmaniasis.
TABLE 3 Time from onset of symptoms to diagnosis in patients with VL and PKDL in a subdistrict of 
Bangladesh using an active case-finding strategy
Days from onset of symptoms/signs to 
diagnosis among cases referred by ORWs
Days from onset of symptoms/signs to 
diagnosis among self-referred cases
VL ORWs (n = 195) Self referrals (n = 892)
Median 60 (7–624) 60 (1–750)
Quartile 1 30 30
Quartile 3 90 90
IQR 60 60
PKDL ORWs (n = 667) Self referrals (n = 478)
Median 360 (1–9000) 345 (1–3600)
Quartile 1 90 90
Quartile 3 720 720
IQR 630 630
VL = visceral leishmaniasis; PKDL = post-kala azar dermal leishmaniasis; ORW = outreach worker; IQR = interquartile range.
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subdistrict, which was inferior to that of the other subdistrict and 
also did not allow collection of data on time taken from onset of 
symptoms to diagnosis for comparison with the ACD subdistrict. 
ACD has been recommended as one of the five pillars of VL 
elimination, combined with early diagnosis and treatment, inte-
grated vector management and surveillance, social mobilisation 
and building partnerships and clinical and operational re-
search.11 Our study shows that ACD is superior to PCD in the de-
tection of VL, although the head-to-head comparison between 
the two districts was difficult due to the limitations mentioned 
above. Studies assessing ACD for VL in Asia, including Bangla-
desh, have shown more positive yields than in our study.12,13 
However, these were conducted in research settings and some-
times used incentives. Screening of the whole community and 
using incentives may be difficult to implement and sustain at the 
routine level. 
In contrast, we found that an ACD strategy using ORWs was 
associated with a considerably higher yield of PKDL. Similar re-
sults under research settings and using trained village volunteers 
have been reported from elsewhere in Bangladesh,14 and this con-
firms our belief that such an approach is effective. As PKDL acts as 
a reservoir of infection, this strategy can contribute to the elimi-
nation of leishmaniasis.
In conclusion, this study conducted in leishmaniasis-endemic 
subdistricts in Bangladesh shows that an ACD strategy using 
ORWs and a symptom- or sign-based approach results in an in-
crease yield of VL and a considerably higher yield of PKDL. This 
approach should be promoted more widely, as it may contribute 
substantially to the elimination of leishmaniasis in South-East 
Asia.15 
References
1 Alvar J, Velez I D, Bern C, et al. Leishmaniasis worldwide and global esti-
mates of its incidence. PLOS ONE 2012; 7: e35671. 
2 Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. Clin Diagn 
Lab Immunol 2002; 9: 951–958.
3 Mohapatra T M, Singh D P, Sen M R, Bharti K, Sundar S, Comparative evalu-
ation of rK9, rK26 and rK39 antigens in the serodiagnosis of Indian visceral 
leishmaniasis. J Infect Dev Ctries 2010; 4: 114–117.
4 Cunningham J, Hasker E, Das P, et al. A global comparative evaluation of 
commercial immunochromatographic rapid diagnostic tests for visceral 
leishmaniasis. Clin Infect Dis 2012; 55: 1312–1319. 
5 Rahman K M, Islam S, Rahman M W, et al. Increasing incidence of post-kala 
azar dermal leishmaniasis in a population-based study in Bangladesh. Clin 
Infect Dis 2010; 50: 73–76.
6 World Health Organization South-East Asia Regional Office. Intercountry 
Meeting of National Programme Managers for Kala-azar Elimination. Behror, 
India, 1–2 September 2005. SEA–VBC–89. New Delhi, India: 2005. http:// 
209.61.208.233/LinkFiles/Kala_azar_VBC-89.pdf Accessed March 2014.
7 Bangladesh Bureau of Statistics. Dhaka, Bangladesh: Bangladesh Bureau of 
Statistics, 2011. http://www.bbs.gov.bd/WebTestApplication/userfiles/Image/
Census2011/Dhaka/Dhaka/Dhaka_C01.pdf Accessed January 2014.
8 Bern C, Chowdhury R. The epidemiology of visceral leishmaniasis in Bangla-
desh: prospects for improved control. Indian J Med Res 2006; 123: 275–288. 
9 Rahman R, Bangali M, Kabir H, Naher F B, Mahboob S. Kala-azar situation in 
Bangladesh. National guideline and training module for kala-azar elimination 
in Bangladesh. 1st ed. Dhaka, Bangladesh: Centers for Disease Control and 
Prevention, Directorate General of Health Services, Ministry of Health and 
Family Welfare, Government of the Peoples’ Republic of Bangladesh, 2008. 
10 Bern C, Hightower A W, Chowdhury R, et al. Risk factors for kala-azar in 
Bangladesh. Emerg Infect Dis 2005; 11: 655–662.
11 Joshi A, Narain J P, Prasittisuk C, et al. Can visceral leishmaniasis be elimi-
nated from Asia? J Vector Borne Dis 2008; 45: 105 – 111. 
12 Singh S P, Hirve S, Huda M M, et al. Options for active case detection of vis-
ceral leishmaniasis in endemic districts of India, Nepal, and Bangladesh, 
comparing yields, feasibility and costs. PLOS Negl Trop Dis 2011; 5: e960.
13 Huda M M, Hirve S, Siddiqui N A, et al. Active case detection in national 
visceral leishmaniasis elimination programs in Bangladesh, India, and Ne-
pal: feasibility, performance and costs. BMC Public Health 2012; 12: 1001.
14 Mondal D, Nasrin K N, Huda M M, et al. Enhanced case detection and im-
proved diagnosis of PKDL in a kala-azar endemic area of Bangladesh. PLOS 
Negl Trop Dis 2010; 4: e832.
15 World Health Organization. Regional strategic framework for elimination of 
kala-azar from the South-East Asia region (2005 – 2015). New Delhi, India: 
South-East Asia Regional Office, WHO, 2012. http://www.searo.who.int/ 
entity/vector_borne_tropical_diseases/documents/SEA-CD-239/en/index.
html Accessed January 2014.
Contexte  :  Deux sous-districts du Bangladesh, Fulbaria et Trishai, où 
la leishmaniose est hyper-endémique.
Objectif  :  Déterminer 1) le nombre de patients ayant eu un 
diagnostic de leishmaniose viscérale (VL) et de leishmaniose dermique 
post-kala azar (PKDL) grâce à une stratégie de détection active des 
cas (ACD) à Fulbaria et à une stratégie de détection passive (PCD) à 
Trishai, et 2) le temps écoulé entre les symptômes et le diagnostic 
dans le sous-district à ACD.
Schéma  :  Etude descriptive transversale des patients diagnostiqués 
entre mai 2010 et décembre 2011. La stratégie ACD comportait une 
éducation des communautés et des stratégies avancées ciblant les 
foyers des patients index grâce à un dépistage basé sur les symptômes 
et au test rK-39 pour les patients suspects.
Résultats  :  Dans les districts de stratégie ACD (Fulbaria) et le sous-
district de stratégie PCD (Trishai), 1088 et 756 patients 
respectivement ont eu un diagnostic de VL et 1145 et 37 
respectivement ont eu un diagnostic de PKDL. Dans ce sous-district, 
le délai médian de diagnostic était de 60 jours pour tous les patients 
atteints de VL, qu’ils soient référés par du personnel des stratégies 
avancées ou viennent d’eux-mêmes. Il était respectivement de 345 et 
360 jours pour la PKDL.
Conclusion  :  Une stratégie ACD au niveau d’un sous-district permet 
de dépister un nombre accru de VL et encore plus de PKDL. Comme 
la PKDL constitue un réservoir d’infection, la stratégie d’ACD et le 
traitement des cas dépistés peuvent contribuer à l’élimination 
régionale de la leishmaniose du sous-continent indien.
Marco de referencia: Los subdistritos de Fulbaria y Trishal en 
Bangladesh, donde es hiper-endémica la leishmaniasis. 
Objetivo: Determinar: 1) el número de pacientes con diagnóstico de 
leishmaniasis visceral (VL) y de leishmaniasis cutánea pos kala azar 
(PKDL) mediante una estrategia de detección activa de casos (ACD) 
en Fulbaria y una detección pasiva (PCD) en Trishal; y 2) y el lapso 
entre la aparición de los síntomas y el diagnóstico en el subdistrito 
que aplicó la estrategia ACD. 
Método: Se llevó a cabo un estudio transversal descriptivo de los 
pacientes en quienes se estableció el diagnóstico de leishmaniasis 
entre mayo del 2010 y diciembre del 2011. Como parte de la 
estrategia ACD se impartió educación a la comunidad y participaron 
trabajadores extrainstitucionales que contactaban a los hogares de 
los casos iniciales y practicaban una detección basada en los síntomas 
y la prueba rK-39 de diagnóstico rápido en los casos de presunción 
diagnóstica. 
Resultados: En el subdistrito de Fulbaria la estrategia ACD permitió 
el reconocimiento de 1088 residentes con VL y 1145 con PKDL; en el 
subdistrito de Trishal se detectaron mediante la estrategia PCD 756 y 
37 casos, respectivamente. La mediana del lapso necesario hasta 
establecer el diagnóstico de VL en los pacientes remitidos 
directamente por los trabajadores periféricos fue análoga a la 
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mediana del lapso en los que se presentaron por su propia iniciativa y 
correspondió a 60 días en casos de VL; en los pacientes con PKDL la 
mediana del lapso fue 360 días en los pacientes remitidos por los 
trabajadores periféricos y 360 en los pacientes que acudieron por su 
propia cuenta. 
Conclusión: Una estrategia ACD a escala del subdistrito ofrece un 
mayor rendimiento diagnóstico de la VL y un incremento aun mayor 
del diagnóstico de PKDL. Dado que la PKDL representa un reservorio 
de la infección, una estrategia ACD y tratamiento puede contribuir a 
la eliminación regional de la leishmaniasis en el subcontinente indio.
